FABP5 and hepatocellular carcinoma: FABP5 protein expression was unaffected by MELK knockdown in hepatoma SK-HEP1 and HCC-LM3 cells after treatment with proteasome inhibitor MG132 (Fig. 5h, Additional file 1: Fig. S8c).